Sign In
Buy GDRX
$2.57
-0.0900 (-3.38%)
At Close: Jun 22, 2026
7 Telehealth Stocks To Buy Ahead Of Flu Season
12:44pm, Friday, 13'th Nov 2020
Telehealth stocks have come to prominence in 2020 for obvious reasons. Read on for those that are positioned to thrive moving forward.
GoodRx Holdings' (GDRX) Management on Q3 2020 Results - Earnings Call Transcript
02:15am, Friday, 13'th Nov 2020
GoodRx Holdings' (GDRX) Management on Q3 2020 Results - Earnings Call Transcript
GoodRx: Long-Term Upside Potential From Platform Integration
03:40pm, Tuesday, 10'th Nov 2020
Recent IPO GoodRx grows quickly in a large TAM with its core prescriptions, telehealth, and pharmaceutical manufacturer solutions offerings. GoodRx just started integrating its core and telehealth ser
Why GoodRx Stock Fell 13% in October
03:39pm, Wednesday, 04'th Nov 2020
Investors and analysts alike wonder what this company is worth.
Why You Probably Shouldn't Buy GoodRx Stock
08:11am, Monday, 02'nd Nov 2020
GoodRx's prescription drug coupons are popular with consumers, but that doesn't necessarily make this healthcare stock a good investment right now.
GoodRx's IPO Is Really That Good
03:09pm, Monday, 14'th Sep 2020
GoodRx has released preliminary IPO details, and the company was worth $2.8 billion in 2018. The company aims to be a major disruptor in the pharmaceutical and telehealth sectors, allowing customers t
GoodRx Files Proposed Terms For $900 Million IPO
02:05pm, Monday, 14'th Sep 2020
GoodRx aims to raise $900 million in an IPO and $100 million in a concurrent private placement. The firm operates an online prescription comparison site and provides other related services.
U.S. IPO Weekly Recap: The IPO Market Gears Up For Fall With Wave Of Filings In A 2 IPO Week
02:43pm, Sunday, 30'th Aug 2020
Two foreign electric vehicle makers and three SPACs went public this past week. A wave of filings brought 27 companies into the IPO pipeline.
U.S. IPO Week Ahead: The Quiet Before The Post-Labor Day IPO Storm
12:44pm, Saturday, 29'th Aug 2020
There are no IPOs scheduled for the week ahead, though a few SPACs may join the IPO calendar. New filings should continue to pour in as well.
